InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
3
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-8.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Benathen Marc David, 首席财务官. Officer active across 2 companies, notably LifeMD, Inc.. In total, 10 disclosures have been recorded. Split: 3 buys · 1 sell. Total volume traded: €895k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 22 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Benathen Marc David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
87,000 股0Common StockSEC:0000912282-25-000910:0
75,000 股@ US$13.0926100.0% 占其流量Common StockSEC:0000912282-25-000692:0
75,000 股0Common StockSEC:0000912282-25-000361:0
87,000 股0Common StockSEC:0000912282-25-000281:0
75,000 股0Common StockSEC:0001362118-24-000009:0
25,000 股0Common StockSEC:0001362118-23-000047:0
25,000 股0Common StockSEC:0001362118-22-000005:0
7,831 股@ US$4.0963.8% 占其流量Common Stock, par value $0.01SEC:0001362118-21-000049:0
标准退出：2022年2月28日 (T+90)
1,297 股@ US$7.2318.0% 占其流量Common StockSEC:0001362118-21-000029:0
标准退出：2021年11月16日 (T+90)
1,099 股@ US$8.933418.1% 占其流量Common StockSEC:0001362118-21-000010:0
标准退出：2021年8月17日 (T+90)
10 条申报中的 10 条
About Benathen Marc David
Marc David Benathen is the Chief Financial Officer of LifeMD, Inc. and LifeMD, Inc. He oversees all financial operations of the company, including financial planning, reporting, and compliance. In his role, Marc ensures that LifeMD maintains high standards of financial integrity and transparency. His experience in finance is crucial to support LifeMD's growth strategy.
